Processa Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that…

Biotechnology
US, Hanover [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Processa Pharmaceuticals, Inc. has no acquisition track records yet.

M&A Deals · History

Processa Pharmaceuticals, Inc. has no acquisition track records yet.

End of PCSA's Analysis
CIK: 1533743 CUSIP: 74275C205 ISIN: US74275C3043 LEI: - UEI: -
Secondary Listings
PCSA has no secondary listings inside our databases.